Transdifferentiation in TSC2 -Mutant Metastatic Pancreatic Neuroendocrine Tumor

This publication has 17 references indexed in Scilit:

• Significance of RB Loss in Unlocking Phenotypic Plasticity in Advanced Cancers
  Molecular Cancer Research, 2023
• Integrated Genomic and Clinicopathologic Approach Distinguishes Pancreatic Grade 3 Neuroendocrine Tumor From Neuroendocrine Carcinoma and Identifies a Subset With Molecular Overlap
  Laboratory Investigation, 2023
• Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms
  Endocrine Pathology, 2022
• Epigenetic landscape of pancreatic neuroendocrine tumours reveals distinct cells of origin and means of tumour progression
  Communications Biology, 2020
• MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance
  Nature Communications, 2017
• Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas
  Clinical Cancer Research, 2016
• mTOR-Raptor Binds and Activates SGK1 to Regulate p27 Phosphorylation
  Molecular Cell, 2008
• sst2 Somatostatin Receptor Mediates Cell Cycle Arrest and Induction of p27
  Journal of Biological Chemistry, 1999
• Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2
  Proceedings of the National Academy of Sciences, 1998
• Rapamycin Resistance Tied to Defective Regulation of p27 ^Kip1
  Molecular and Cellular Biology, 1996